CVS Health Boosts 2025 Outlook, Forecasts Strong 2026 Growth
CVS Health raises 2025 revenue guidance to $400B and projects adjusted earnings of $7.00-$7.20 per share for 2026, signaling turnaround momentum under CEO David Joyner.
/ 2 items
CVS Health raises 2025 revenue guidance to $400B and projects adjusted earnings of $7.00-$7.20 per share for 2026, signaling turnaround momentum under CEO David Joyner.
Oscar Health reports third quarter loss amid rising healthcare costs but plans return to profitability in 2026 through rate increases and market expansion in ACA insurance space.